GDC6036；GDC6036 atropisomer

Non Chimik:

2-Propen-1-yon, 1-[(3S)-4-[7-[6-amino-4-methyl-3-(trifluorometil)-2-piridinil]-6-chloro-8-fluoro-2- [[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]-

Kòd SMILES:

C=CC(N1C[C@H](C)N(C2=C3C=C(Cl)C(C4=NC(N)=CC(C)=C4C(F)(F)F)=C(F) )C3=NC(OC[C@H]5N(C)CCC5)=N2)CC1)=O

Kòd InChi:

InChI=1S/C29H32ClF4N7O2/c1-5-21(42)40-9-10-41(16(3)13-40)27-18-12-19(30)22(26-23(29(32), 33)34)15(2)11-20(35)36-26)24(31)25(18)37-28(38-27)43-14-17-7-6-8-39(17) 4/h5,11-12,16-17H,1,6-10,13-14H2,2-4H3,(H2,35,36)/t16-,17-/m0/s1

InChi kle:

ZRBPIAWWRPFDPY-IRXDYDNUSA-N

Mot:

2417917-17-8；CAS:2417917-17-8；CAS:2417917-17-8；GDC6036 atropisomer; GDC-6036; GDC 6036; GDC6036

Solibilite: 

Depo:Sèk, nwa ak nan 0 - 4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

GDC6036 anti wotasyon izomè a gen de kalite GDC6036 anti wotasyon izomè. GDC-6036， Epitou li te ye kòm RG6330, li se yon byodisponib oral, trè efikas, ak selektif KRAS G12C inibitè.

Sib: KRAS G12C